Logo-bi
Bioimpacts. 2019;9(1): 1-3. doi: 10.15171/bi.2019.01
PMID: 30788254        PMCID: PMC6378097

Editorial

Indoleamine 2, 3-dioxygenase inhibitors in immunochemotherapy of breast cancer: challenges and opportunities

Nastran Hashemzadeh 1,2, Khosro Adibkia 1,3 ORCID, Jaleh Barar 1,3 * ORCID

Cited by CrossRef: 0



BioImpacts, as a peer-reviewed international journal, publishes all types of papers on bench-to-bedside translational aspects of pharmaceutical and biomedical sciences. As a "Publish Free" and "Access Free" journal, BioImpacts follows a constructive peer-review process with free editing service to benefit the scientific community worldwide.